Emergent BioSolutions
EBS
#8541
Rank
ยฃ0.20 B
Marketcap
ยฃ3.93
Share price
-6.36%
Change (1 day)
-48.05%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -ยฃ3.79

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -ยฃ3.85. In 2025 the company made an earnings per share (EPS) of ยฃ0.73 an increase over its 2024 EPS that were of -ยฃ2.77.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ3.79-622.36%
2025ยฃ0.73-126.17%
2024-ยฃ2.77-75.61%
2023-ยฃ11.37232.21%
2022-ยฃ3.42-203.46%
2021ยฃ3.31-25.09%
2020ยฃ4.41445.28%
2019ยฃ0.81-15.2%
2018ยฃ0.95-35.9%
2017ยฃ1.4969.57%
2016ยฃ0.88-27.67%
2015ยฃ1.2165.62%
2014ยฃ0.7311.63%
2013ยฃ0.6632.31%
2012ยฃ0.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.76-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.20-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-ยฃ1.37-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ0.40-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ3.32-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.34-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel